Publications

Biological effects of anti-ErbB2 single chain antibodies selected for internalizing function.

Neve RM, Nielsen UB, Kirpotin DB, Poul MA, Marks JD, Benz CC

Biochemical and biophysical research communications
. Jan 12, 2001
Engineering and characterization of a novel fusion protein incorporating B7.2 and an anti-ErbB-2 single-chain antibody fragment for the activation of Jurkat T cells.

Marshall KW, Marks JD

Journal of immunotherapy (Hagerstown, Md. : 1997)
. Jan 1, 2001
Lung collapse during low tidal volume ventilation in acute respiratory distress syndrome.

Kallet RH, Siobal MS, Alonso JA, Warnecke EL, Katz JA, Marks JD

Respiratory care
. Jan 1, 2001
The Internet for nuclear magnetic resonance spectroscopists.

Avizonis D, Farr-Jones S

Methods in enzymology
. Jan 1, 2001
Targeting of bivalent anti-ErbB2 diabody antibody fragments to tumor cells is independent of the intrinsic antibody affinity.

Nielsen UB, Adams GP, Weiner LM, Marks JD

Cancer research
. Nov 15, 2000
Applying phage antibodies to proteomics: selecting single chain Fv antibodies to antigens blotted on nitrocellulose.

Liu B, Marks JD

Analytical biochemistry
. Nov 1, 2000
Mass spectral analysis of a protein complex using single-chain antibodies selected on a peptide target: applications to functional genomics.

Siegel RW, Allen B, Pavlik P, Marks JD, Bradbury A

Journal of molecular biology
. Sep 15, 2000
Measuring intra-esophageal pressure to assess transmural pulmonary arterial occlusion pressure in patients with acute lung injury: a case series and review.

Kallet RH, Katz JA, Pittet JF, Ghermey J, Siobal M, Alonso JA, Marks JD

Respiratory care
. Sep 1, 2000
Selection of tumor-specific internalizing human antibodies from phage libraries.

Poul MA, Becerril B, Nielsen UB, Morisson P, Marks JD

Journal of molecular biology
. Sep 1, 2000
Chemokine antagonists as anti-inflammatory and antiviral agents II.

Farr-Jones S

IDrugs : the investigational drugs journal
. Jun 1, 2000